NeuroBo Pharmaceuticals, Inc.

NasdaqCM:NRBO Stock Report

Market Cap: US$20.4m

NeuroBo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:NRBO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Sep 24SellUS$1,526Dong-A ST Co., Ltd.Company407US$3.75
23 Jun 24BuyUS$10,000,003Dong-A ST Co., Ltd.Company2,544,530US$3.93

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NRBO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders73,0300.848%
Private Companies150,3541.75%
Institutions272,4023.16%
Hedge Funds848,0009.84%
General Public1,924,43222.3%
Public Companies5,347,79262.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 77.6%.

Top Shareholders

Top 25 shareholders own 77.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
62.1%
Dong-A ST Co., Ltd.
5,347,792US$12.7m-0.01%no data
9.84%
Armistice Capital LLC
848,000US$2.0m21.7%0.05%
1.75%
Strategic Risk, Llc.
150,354US$356.3k0%no data
1.04%
Affinity Asset Advisors, LLC
89,222US$211.5k0%0.04%
0.7%
The Vanguard Group, Inc.
60,452US$143.3k27.7%no data
0.38%
Geode Capital Management, LLC
32,574US$77.2k41.2%no data
0.32%
Hyung-Heon Kim
27,600US$65.4k0%no data
0.29%
E&Investment, Inc.
25,069US$59.4k0%3.34%
0.18%
Ferguson Wellman Capital Management, Inc.
15,670US$37.1k0%no data
0.18%
State Street Global Advisors, Inc.
15,633US$37.0k0%no data
0.16%
Northern Trust Global Investments
13,508US$32.0k0%no data
0.15%
UBS Asset Management AG
12,952US$30.7k0%no data
0.11%
Andrew Koven
9,767US$23.1k38.9%no data
0.11%
D. Strickland
9,766US$23.1k38.9%no data
0.11%
Michael Salsbury
9,766US$23.1k38.9%no data
0.11%
Jason Groves
9,766US$23.1k38.9%no data
0.061%
BlackRock, Inc.
5,274US$12.5k0%no data
0.045%
Mark Glickman
3,907US$9.3k24.9%no data
0.029%
James Tursi
2,458US$5.8k-0.04%no data
0.017%
Tower Research Capital Europe Limited
1,431US$3.4k40.7%no data
0.0067%
Dimensional Fund Advisors LP
576US$1.4k0%no data
0.00034%
Bank of America Corporation, Asset Management Arm
29US$69.4-81.8%no data
0.00008%
JPMorgan Chase & Co, Brokerage and Securities Investments
7US$16.340%no data
0.00005%
BNP Paribas Arbitrage Sa, Asset Management Arm
4US$10.20%no data
0.00001%
Merrill Lynch & Co. Inc., Banking Investments
1US$2.00%no data